Search

Your search keyword '"Zou, Huachun"' showing total 19 results
Start Over Author "Zou, Huachun" Publisher biomed central
19 results on '"Zou, Huachun"'

2. Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis

Author

Wu, Xinsheng, Wu, Guohui, Ma, Ping, Wang, Rugang, Li, Linghua, Sun, Yinghui, Xu, Junjie, Li, Yuwei, Zhang, Tong, Li, Quanmin, Yang, Yuecheng, Wang, Lijing, Xin, Xiaoli, Qiao, Ying, Fang, Bingxue, Lu, Zhen, Zhou, Xinyi, Chen, Yuanyi, Liu, Qi, Fu, Gengfeng, Wei, Hongxia, Huang, Xiaojie, Su, Bin, Wang, Hui, and Zou, Huachun

Published
2023
Full Text
View/download PDF

18. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.

Author

Li, Jinghua, Peng, Liping, Gilmour, Stuart, Gu, Jing, Ruan, Yuhua, Zou, Huachun, Hao, Chun, Hao, Yuantao, and Lau, Joseph Tak-fai

Subjects
HIV prevention, HIV-positive men, MEN who have sex with men, PRE-exposure prophylaxis, HIGHLY active antiretroviral therapy, HIV infection transmission, QUALITY of life
Abstract

Background: The new HIV treatment guidelines in China recommend antiretroviral therapy (ART) for all people living with HIV, but significant gaps in implementation still exist. Pre-exposure prophylaxis (PrEP) can effectively reduce the risk of HIV transmission among men who have sex with men (MSM). This study assessed the epidemiological impact and cost effectiveness of PrEP, enhanced biomedical interventions and their combination among MSM in China.Methods: A deterministic mathematical model was developed and projected over 20 years to assess the impact of the PrEP, biomedical interventions and their combinations. Incidence and prevalence of HIV were measured, and cost-effectiveness was assessed using incremental cost (international dollars, Int.$) per quality-adjusted life year (QALY) gained.Results: A total of 0.78 million new HIV infections were estimated to occur over the next 20 years if no additional interventions are implemented among MSM. The PrEP-only strategy covering 25-75% of HIV-negative high-risk MSM can prevent 0.09-0.20 million (12.1-25.7%) new infections, at a cost of 17,277-18,452 Int.$/QALY. The optimal cost-effectiveness path is from test-and-treat to the combination strategy of test-and-treat and PrEP. Some strategies could almost eliminate new HIV infections over the next 20 years.Conclusions: PrEP, test-and-treat, and their combinations among MSM are effective and cost-effective relative to current policy. PrEP is an important and cost-effective addition to current policy in China. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

19. The prevalence of anal human papillomavirus among young HIV negative men who have sex with men.

Author

Zou, Huachun, Fairley, Christopher K, Hocking, Jane S, Garland, Suzanne M, Grulich, Andrew E, and Chen, Marcus Y

Abstract

Men who have sex with men (MSM) especially those who are HIV positive are at risk for HPV-associated anal cancer. We systematically reviewed studies with data on the prevalence of vaccine preventable anal HPV among men who have sex with men aged 25 or younger and identified 6 studies. None of these studies were specifically designed to determine the prevalence of HPV in this population. Available data, albeit limited, suggest many young MSM may not already be HPV infected. Further studies using representative sampling focused on teenage MSM are required to confirm this. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results